Metered Dose Inhalers Market Size, Share, Trends, Analysis To 2032

How big is the Metered Dose Inhalers Market?

According to the report published by Zion Market Research, the global Metered Dose Inhalers Market size was valued at USD 17.40 Billion in 2023 and is predicted to reach USD 23.82 Billion by the end of 2032. The market is expected to grow with a CAGR of 3.2% during the forecast period. The report analyzes the global Metered Dose Inhalers Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Metered Dose Inhalers industry.

Request Free Sample

Metered Dose Inhalers Market: Overview

The metered dose inhaler is a form of respiratory device that transfers a specific amount of medication into the lungs. In the medicine container, the medication is filled and the patient itself uses it in the form of a short burst of sprays of a fixed dosage and inhales it. The medication is inhaled directly into the lungs.

Metered Dose Inhalers Market: Facts

The National Health Technology Assessment Inhaler Review Group performed research in order to review the clinical effectiveness of metered dose inhalers and the handheld inhaler devices in order to transmit the medications. The review concluded that the metered dose inhaler is a cost-effective option.

Request Free Sample

Metered Dose Inhalers Market: Segmentation

The global market for the metered dose inhalers is fragmented into its product type, dose type, disease type, and technology.

Based on the type of the product, the global market is segregated into dry powdered inhaler, pressurized metered dose inhalers, nebulizers, and connected metered dose inhalers.

Based on the type of the dosage, the market is categorized into 250–400 doses, 200–250 doses, 170–200 doses, 100–160 doses, and 50–80 doses.

Based on the type of the disease, the market is divided into chronic obstructive pulmonary devices, asthma, and other respiratory devices.

Based on the technology, the market is bifurcated into hydrofluoroalkane propellant, chlorofluorocarbons, and others.

Metered Dose Inhalers Market: Growth Factors

In the coming years, the metered-dose inhaler market will grow at an above-average rate. The key factor that is driving the metered dose inhaler market is the rapid development of the healthcare industry and the pharmaceutical sector. In recent years, there has been a rise in the prevalence of diseases that are related to the respiratory system, such as chronic obstructive pulmonary diseases, asthma, chronic respiratory diseases, and others.

The demand for the metered dose inhalers has increased owing to the rise in the awareness among people about the advanced respiratory devices that have beneficial features when compared with the traditional treatment methods, thus propelling the growth of the market. The increase in pollution is another factor that favors the growth of the metered dose inhalers market. The factors that are limiting the growth of the market are the increased production cost of the metered dose inhaler and the medication side effects.

Metered Dose Inhalers Market: Report Scope

Metered Dose Inhalers Market: Regional Analysis

The market for metered dose inhalers is dominated by regions such as Asia Pacific and North America. These regions dominate the market both in terms of volume and value. Factors that favor the growth of the market are the increasing awareness among people about respiratory diseases and the increasing development in the healthcare and pharmaceutical industries. In the North American region, the country that holds the maximum share of metered dose inhalers is the U.S. In Asia Pacific region, the developing nations China and India are the major producers of metered dose inhalers.

Metered Dose Inhalers Market: Competitive Players

The key market players that are involved in the metered dose inhalers market include

• Presspart Manufacturing Ltd.
• Beximco Pharma Ltd.
• 3M Pharmaceuticals Pty Ltd.
• Anomatic Innovation & Design Center & Manufacturing
• Intech Biopharm Corporation
• Cipla Inc.
• Midascare Pharmaceuticals Pvt. Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• Biocare Manufacturing Sdn Bhd
• Aristo Pharma Ltd
• Swiss Pharmaceuticals Pvt. Ltd.
• others

By Product Type

• dry powdered inhaler
• pressurized metered dose inhalers
• nebulizers
• connected metered dose inhalers.

By Dosage Type

• 250–400 doses
• 200–250 doses
• 170–200 doses
• 100–160 doses
• 50–80 doses.

By Disease Type

• chronic obstructive pulmonary devices
• asthma
• other respiratory devices.

By Technology

• hydrofluoroalkane propellant
• chlorofluorocarbons
• others.

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provide

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonies to companies in order to fortify their foothold in the market.